Mitch Sanders

Chief Scientific Officer at Woundforce

Mitchell Sanders MS, PhD, has over 30 years of experience in preclinical animal models and clinical product development in advanced wound care. With ECI Biotech and Alira Health, Mitchell has produced over 12 peer-reviewed publications and 40 world wide patents in medical device and in vitro diagnostics. Mitchell is an expert in clinical and translational research and is a reviewer for the Wound Healing Society, Wounds International, Tissue Engineering, CIMIT, MassVentures, MIT, WPI, TechSandbox, PiranhaPond, SBANE and the Venture Forum. Mitchell has an MS and PhD from WPI in molecular biology and biomedical sciences with 2 Postdocs (biochemistry and pathogen genetics) at the Whitehead Institute/MIT.

Peers

View in org chart

Timeline

  • Chief Scientific Officer

    Current role